- Study 1 was a meta-analysis of 67 studies (6,899 patients and controls), and Study 2 was a cross-sectional analysis of UK Biobank data (37,139 participants with chronic pain and controls).
- Study 2 used a predictive model of cognitive age to compare chronic pain with neurological and psychiatric conditions, with healthy controls as the reference group.
- The meta-analysis found moderate cognitive deficits in chronic pain (g = -0.48, 95% CI -0.52 to -0.43, I² = 82.03), while UK Biobank effects were smaller (d = 0.04-0.30).
- Participants with 4 or more pain sites showed an advanced cognitive age pattern, and the authors suggest further clinical evaluation if impairment seems disproportionate to pain severity.
Latest papers
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- Systematic review and network meta-analysis of 96 RCTs (N=7396) comparing exercise prehabilitation interventions and their components before surgery.
- Combined aerobic, pulmonary, and functional exercise was most likely to reduce complications (P-score 0.94; OR 0.16, 95% CI 0.05-0.60; very low certainty).
- Combined aerobic, pulmonary, and functional exercise was also most likely to shorten length of stay (P-score 0.97; MD -3.4 days, 95% CI -5.7 to -1.0; moderate certainty).
- Combined aerobic and strength exercise ranked highest for health-related quality of life (SMD 0.67, 95% CI 0.07-1.27; low certainty), while no intervention significantly improved physical recovery.
- Systematic review of 207 randomized controlled trials including 63,785 adults undergoing cardiac surgery, evaluating 55 pharmacological and non-pharmacological interventions to prevent cardiac surgery-associated acute kidney injury.
- Most included trials were small (median sample size 120) and single-center (76.7%), and most reported neutral results (149 of 206).
- Dexmedetomidine (OR 0.48, 95% CI 0.29-0.80), fenoldopam (OR 0.57, 95% CI 0.33-0.98), nitric oxide (OR 0.61, 95% CI 0.43-0.88), and remote ischemic preconditioning (OR 0.78, 95% CI 0.67-0.90) were associated with lower odds of CSA-AKI.
- The authors conclude that only a limited number of interventions were associated with lower odds of CSA-AKI and that these findings need cautious interpretation and confirmation in adequately powered RCTs.
- Bayesian network meta-analysis of 22 RCTs (1,699 patients) on preventing and treating rebound pain after brachial plexus block for upper-limb surgery.
- Six interventions were compared against placebo: dexamethasone, esketamine, dexmedetomidine, liposomal bupivacaine, continuous nerve block and combined nerve block.
- Versus placebo, dexamethasone (OR 0.22, 95% CI 0.11 to 0.42), dexmedetomidine (OR 0.23, 0.08 to 0.68) and continuous nerve block (OR 0.04, 0.01 to 0.33) reduced rebound pain incidence.
- Dexamethasone and continuous block lowered 12-hour pain scores, and combined block lowered 24-hour scores; the authors call the evidence exploratory and hypothesis-generating.
- Systematic review and meta-analysis of 67 double-blind, placebo-controlled studies in healthy volunteers (N = 2706) testing acute peripheral pain.
- Compared centrally active opioid antagonists with placebo during pain testing, using a three-level random-effects meta-regression across intensity, tolerance, unpleasantness, and threshold.
- Mu-opioid blockade was associated with slightly higher pain than placebo (Hedges' g = 0.18, 95% CI 0.11 to 0.25), about 2.8 points on a 0-100 scale; I² was 66%.
- Reporting bias likely overestimated the effect, and study characteristics explained little heterogeneity; the authors conclude endogenous opioids play a minor role in human acute pain regulation.
- Systematic review of 10 preclinical and 10 clinical studies comparing flow-controlled ventilation (FCV) with conventional ventilation, searching MEDLINE and CENTRAL through May 2026.
- FCV actively regulates inspiration and expiration at a constant, predefined flow; clinical studies were split between compliance-guided titration (six) and fixed or protocolized targets (four).
- Preclinical studies consistently showed lower respiratory rate and minute ventilation with maintained or improved oxygenation, while clinical results were more heterogeneous, with no pooled effect sizes reported.
- The authors conclude FCV may improve ventilatory efficiency and oxygenation without adverse hemodynamic effects, but rate clinical certainty as low to moderate and call for standardization and larger trials.
- Systematic review and dual frequentist-Bayesian meta-analysis of seven randomized trials (n=2408) in adults with septic shock.
- Compared peripheral perfusion-guided resuscitation with standard care or lactate-guided resuscitation for 28-day mortality.
- The pooled risk ratio was 0.87 (95% CI 0.76-1.01; p=0.06), with the interval crossing no effect and I² of 0%.
- The Bayesian analysis gave a 97.2% posterior probability that RR is below 1, but the authors note the magnitude of any effect remains uncertain.
- Systematic review and meta-analysis of 39 studies (n=2652) in adults with chronic non-cancer pain treated with intrathecal drug delivery.
- Twenty single-arm comparisons contributed to the pain-intensity meta-analysis at 12 months, so there was no controlled comparator.
- Pooled pain reduction from baseline was 2.64 (95% CI 2.19 to 3.08), with a 75% probability of exceeding the 2-unit MCID (95% CI 68% to 83%).
- All studies reported functional and HRQoL improvements, but adverse event reporting was inconsistent and certainty of evidence was low.
- Systematic review and meta-analysis of 27 randomized controlled trials including 3041 patients undergoing surgery, searched from inception to December 2025.
- Perioperative vitamin C was compared with control; the review pooled effects on pain, opioid use, rescue analgesia, nausea and vomiting, and CRPS-1.
- Vitamin C reduced pain at 24 h (SMD -0.69, 95% CI -0.98 to -0.40) and 24-h morphine use (MD -4.25 mg, 95% CI -6.14 to -2.35), with rescue analgesia also reduced (RR 0.63, 95% CI 0.47 to 0.84).
- Authors say evidence may support reduced acute pain and opioid use with a favorable safety profile, but heterogeneity and publication bias limit it, and routine recommendation is not yet supported; CRPS-1 risk was lower in high-risk orthopedic patients (RR 0.36, 95% CI 0.23 to 0.58).
- Systematic review of 102 cluster randomized trials in critical care, published 2004 to 2022 and indexed in MEDLINE and Embase, assessing ethical and methodological reporting.
- Compares reporting features across trial designs, including parallel-arm (47%), two-period crossover (23%), stepped-wedge (20%), and multi-period crossover (8%) designs.
- Consent was reported in 75% of trials that identified patients or caregivers as participants, with waived consent most common (49%); only 23% reported consent for healthcare providers.
- Most trials (80%) reported a sample size calculation, but only 13% of trials with fewer than 40 clusters reported a small sample correction.
AI summary not available. Read the source abstract on PubMed.
- Systematic review and meta-analysis of 12 randomised trials (n = 739) comparing remimazolam with sevoflurane for general anaesthesia maintenance or deep sedation.
- Remimazolam was compared with sevoflurane, with outcomes covering intraoperative haemodynamic stability and postoperative nausea and vomiting.
- Remimazolam reduced the risk of intraoperative hypotension versus sevoflurane, RR 0.38 (95% CI 0.25 to 0.57; P < 0.001).
- MAP and heart rate differences appeared only at specific time points, and the PONV reduction came from sensitivity analyses, not the primary analysis.
- Systematic review and meta-analysis of 4 RCTs (7 reports, 446 randomized adults) comparing perioperative subcutaneous liraglutide with placebo or insulin-based usual care in cardiac surgery.
- Liraglutide was compared with placebo or insulin usual care, with glycemic efficacy and hypoglycemia risk as the central questions.
- Liraglutide did not change 30-day mortality (1/161 vs 3/160; RR 0.42, 95% CI 0.06-2.81) or the composite postoperative complication outcome (RR 0.92, 95% CI 0.74-1.14).
- Hypoglycemia was similar (8/165 vs 9/166; RR 0.85, 95% CI 0.34-2.13), and nausea/vomiting estimates were very imprecise (RR 3.01, 95% CI 0.26-35.27).
- This systematic review and meta-analysis pooled 79 randomized trials with 9,340 adults undergoing noncardiac surgery, mostly single-center, with abdominal surgery most common.
- RIPC was compared with standard care or sham, and was mainly delivered by inflating a blood pressure cuff on the upper limb.
- Overall mortality was not significantly reduced (OR 0.79; 95% CI, 0.51-1.24; P=.30), but pre-induction RIPC was linked to lower mortality (OR 0.37; 95% CI, 0.17-0.81; P=.013).
- Exploratory results suggested fewer strokes (OR 0.41; 95% CI, 0.22-0.78), shorter stays, and lower peak NGAL; authors call for more study of pre-induction RIPC.
- Systematic review and meta-analysis of 21 fluoroscopically guided RCTs on caudal, transforaminal, and interlaminar epidural injections for lumbar disc herniation, searching 2020 to March 2026.
- Trials compared local anesthetic with steroid against local anesthetic alone, or against placebo or an active control.
- Best-evidence synthesis graded local anesthetic with steroid as Level I for transforaminal and interlaminar injections and Level II for local anesthetic alone; caudal injections reached Level II for both. The abstract reports no pooled effect sizes or CIs.
- Authors note that few studies reported outcomes of at least 6 months, and that conventional dual-arm meta-analysis was feasible only for interlaminar injections.
- This is a guideline summary combining a systematic literature review from 1966 to October 2025, GRADE appraisal, and modified Delphi consensus on facet joint interventions for chronic axial spinal pain.
- It covers controlled diagnostic medial branch blocks and therapeutic options, including radiofrequency ablation, facet nerve blocks, and intraarticular injections, across the cervical, thoracic, and lumbar spine.
- Diagnostic medial branch blocks use an 80% pain-relief threshold with moderate to strong recommendations, while cervical and lumbar RFA and therapeutic nerve blocks in all regions received moderate recommendations at Level II evidence.
- Cost-utility estimates were $4,664 to $5,446 per QALY for lumbar and $4,994 to $5,364 for cervical interventions, and the authors call for more thoracic, intraarticular, and comparative research.
- Systematic review of 13 randomized controlled trials of physical activity-based interventions in surgical patients assessed at three or more months after surgery, pooling 1155 patients across four surgery types.
- Physical activity programs, varying in modality, duration, frequency and session length, were compared with control groups, and only two studies used active controls.
- The authors reported low-quality evidence that physical activity significantly reduced chronic post-surgical pain versus control, with two studies showing reductions exceeding minimal clinically important differences; only three studies were rated low risk of bias.
- The authors concluded the evidence is insufficient to establish definitive efficacy and recommended clearly defined intervention parameters, active controls and more comprehensive pain assessments in future trials.
- Systematic review of four observational studies (n = 2,824) comparing VA-ECMO plus mechanical thrombectomy with VA-ECMO alone in high-risk PE.
- Only two studies (n = 47) supplied extractable count data, so the pooled estimates rest on very few patients.
- Pooled ORs for in-hospital mortality (0.36; 95% CI, 0.01-13.59) and 90-day mortality (0.43; 95% CI, 0.02-10.66) were imprecise and discordant.
- Neither the nationwide study (aOR 0.75, 95% CI 0.47-1.19) nor the multicenter cohort (HR 0.68, 95% CI 0.45-1.03) reached significance.
- Systematic review and diagnostic meta-analysis of 22 studies, with 13 included in the pooled analysis (n = 1,999 patients), comparing lung ultrasound against chest radiography or CT for ARDS.
- The index test was lung ultrasonography, with chest x-ray or computed tomography as the reference standard; scanning protocols and diagnostic thresholds varied across studies.
- Pooled sensitivity was 0.69 (95% CI, 0.54 to 0.81; I² = 82.9%, low certainty) and pooled specificity was 0.95 (95% CI, 0.85 to 0.98; I² = 88%, moderate certainty).
- The authors conclude that lung ultrasound is better at confirming ARDS (higher specificity) than excluding it (moderate sensitivity), with substantial between-study heterogeneity.
- Systematic review and meta-analysis of 163 RCTs and observational studies including 78,053 adults receiving ECMO, with outcomes at 6 months or later.
- Pooled analyses compared long-term mortality across ECMO modalities (venovenous, venoarterial, and extracorporeal CPR) and clinical indications.
- At 1 year, pooled mortality was 37.2% (95% CI, 30.0-45.1%) for venovenous, 55.2% (95% CI, 50.2-60.1%) for venoarterial, and 74.4% (95% CI, 71.4-77.2%) for ECPR.
- Functional outcomes were reported in only 38 of 163 studies and were inconsistent, so the authors call for standardized reporting and benchmarking.
- Systematic review and meta-analysis of 55 observational studies, with 21 contributing to the meta-analyses, in acutely admitted adult ICU patients.
- Exposure was pre-admission frailty or functional dependency, compared with non-frail or independent status.
- Non-frail versus frail participants had RR 0.62 (95% CI 0.58-0.67, P<0.01) for all-cause mortality; independent versus dependent had RR 0.47 (95% CI 0.40-0.54, P<0.01).
- The authors conclude that frailty and dependency were associated with higher mortality, but certainty of evidence was very low and heterogeneity was substantial.
- Systematic review of 149 included studies, involving more than 3300 anaesthesia staff across 37 countries, searching five databases for translational simulation in multidisciplinary anaesthetic care.
- Studies were included if they used translational simulation to explore or improve anaesthetic care; the review synthesised applications, processes and implementation factors rather than comparing an intervention with a control.
- Most studies used translational simulation to identify latent safety threats and optimise protocols, with structural or procedural changes reported in 113 studies, and nine process domains containing 90 translational processes were identified.
- Applications focused mainly on crisis management rather than routine perioperative care, and signals of improved patient outcomes were reported but causal attribution remains limited by mostly quasi-experimental designs.
- Systematic review and meta-analysis of 21 randomized controlled trials including 1271 adults undergoing spinal surgery.
- The exposure was perioperative intravenous magnesium sulfate, with a control group for comparison.
- Magnesium reduced 24-hour pain scores (MD -0.55, 95% CI -1.01 to -0.10, P = 0.02) and opioid consumption (MD -4.95 mg, 95% CI -8.74 to -1.15 mg, P = 0.01).
- Magnesium was associated with less postoperative nausea and vomiting but more hypotension, and with prolonged time to follow commands and recover orientation.
- Systematic review of 13 eligible studies, eight of them clinical studies in patients, covering adults and children.
- The review examined seven videolaryngoscopy classification tools, including the Cormack-Lehane classification, VIDIAC and PeDiAC scores.
- Accuracy or performance was reported for only three tools, with the Cormack-Lehane classification showing limited performance; no pooled estimates were reported.
- Overall risk of bias was high, and the authors conclude that current evidence is limited and higher-quality research is needed.
- This systematic review pooled eight case-control studies comparing Parkinson's patients with pain, without pain, and healthy controls, totaling 432, 225, and 257 participants.
- The exposure was pain status in Parkinson's disease, examined with structural and resting-state fMRI rather than a treatment intervention.
- Structural MRI showed prefrontal cortical thinning and reduced insular gyrification, and putamen activity was negatively correlated with pain while raphe connectivity was positively associated. The abstract reports no pooled effect sizes, CIs, or p values.
- The authors propose a network-based framework for Parkinson's pain and call for multimodal, longitudinal studies by pain subtype and dopaminergic response. Dynamic default mode and frontoparietal connectivity showed no consistent pain links.
- Systematic review and meta-analysis of nine observational studies (n = 1,855) of patients receiving continuous-flow LVADs.
- No intervention was studied; vasoplegia after implantation was the exposure, assessed for incidence, predictors, and outcomes.
- Vasoplegia occurred in 34.2% of patients (95% CI 26.9%-42.4%) and was linked to higher early mortality, major bleeding, worse long-term survival, and longer stays.
- Male sex and higher BMI were predictors and higher blood pressure was protective, while ICU mortality, acute kidney injury, stroke, and right heart failure did not differ.
- Systematic review and meta-analysis of 13 studies (12 retrospective cohorts, 1 multicenter RCT) covering 1,030,883 surgical patients, 16.6% of whom had intraoperative handover.
- Compared patients with versus without intraoperative anesthesia handover on postoperative morbidity and mortality; the exploratory pooled analysis included 7 studies with 485,623 patients.
- The pooled composite morbidity and mortality outcome was not significantly associated with handover (aOR 1.04; 95% CI 0.98-1.11; P = 0.18; I² = 72%).
- Authors found no consistent independent association, but heterogeneity and residual confounding limit causal interpretation; the RCT found no significant effect on 30-day outcomes.
- Systematic review and meta-analysis of 27 studies (n = 21,908) of children under 18 undergoing noncardiac surgery, assessing KDIGO-defined AKI within 7 postoperative days.
- Pooled incidence was reported separately by population because overall pooling was judged uninterpretable given heterogeneity (I² = 98.7%).
- Reported incidence was 22.3% (95% CI 11.2-39.3) after neonatal surgery, 30.1% (95% CI 21.4-40.6) after pediatric liver transplantation, and 9.2% (95% CI 3.3-23.6) in mixed pediatric surgical populations.
- Within mixed surgical populations, AKI rose with higher ASA class (2.4% in ASA 1-2 to 18.9% in ASA 4-5) and fell with age; the authors conclude the true incidence remains uncertain, with certainty rated low to very low.
- Systematic review and meta-analysis of 11 randomised trials, including 3904 propofol-based and 3907 volatile-based patients undergoing curative cancer surgery.
- Compared propofol-based with volatile-based anaesthesia for adults having curative cancer surgery, with outcomes pooled using random-effects meta-analysis.
- No significant difference in overall survival (HR 1.05, 95%CI 0.94-1.17, p = 0.42) or recurrence-free survival (HR 1.06, 95%CI 0.95-1.19, p = 0.31).
- Mortality (RR 1.03, 95%CI 0.94-1.13) and recurrence (RR 0.92, 95%CI 0.76-1.12) showed no significant effect, though the authors call recurrence findings inconclusive on trial sequential analysis.
- This systematic review pooled 12 case reports describing 13 adults who developed gastroparesis while taking a GLP-1 receptor agonist.
- Semaglutide was the agent most often implicated, followed by liraglutide, dulaglutide, and exenatide, with symptoms often following dose escalation or inappropriate re-initiation.
- Stopping the causative GLP-1 receptor agonist resolved symptoms in all reported patients, though the review reports no effect sizes or confidence intervals.
- The authors call for awareness of this association and recommend careful patient selection, gradual dose titration, and monitoring for persistent GI symptoms.
- Systematic review and meta-analysis of 15 RCTs including 3,274 older adults undergoing cardiac surgery.
- Perioperative dexmedetomidine was compared with placebo or alternative sedative or analgesic regimens for preventing postoperative delirium.
- Dexmedetomidine lowered postoperative delirium incidence (RR 0.70, 95% CI 0.56 to 0.86, p = 0.001; moderate certainty) but increased reported bradycardia (RR 2.08, 95% CI 1.31 to 3.31).
- The benefit appeared larger against active comparators than placebo or saline. The delirium duration reduction (MD -1.12 days) was low certainty with high heterogeneity.
- Systematic review and meta-analysis of 21 RCTs (n = 1828) comparing bundled multimodal anesthesia with opioid-based general anesthesia in adults having elective surgery.
- MMA was defined as opioids plus at least two adjuncts, such as regional techniques, dexmedetomidine, ketamine, or intravenous lidocaine.
- No clear pain difference at 24 h (MD -0.6, 95% CI -1.5 to 0.2; very low certainty), but PONV was reduced (RR 0.59, 95% CI 0.44 to 0.77; low certainty).
- Opioid use fell by 7.0 mg MME (95% CI -12.8 to -1.3; moderate certainty), persisting at 48 h and study end; QoR-15 and pulmonary data were too sparse to pool.
- Meta-analysis with trial sequential analysis of RCTs in pediatric ENT surgery; ten trials were identified and six (414 patients) were pooled.
- Low-dose propofol given before extubation was compared with placebo for emergence agitation and related outcomes.
- Propofol reduced emergence agitation incidence (RR 0.57, 95% CI 0.42-0.78) and severity (MD -3.94, 95% CI -5.74 to -2.13).
- Time to extubation was slightly longer (MD 1.8 min, 95% CI 1.4-2.3), with no difference in recovery time or PACU length of stay.
- This PROSPECT systematic review pooled 176 randomised trials and eight systematic reviews on analgesia after major oncological breast surgery.
- Recommended options include paracetamol, NSAIDs or COX-2 inhibitors, dexamethasone, several single-shot regional blocks, local infiltration analgesia, and pre- and postoperative physiotherapy.
- Gabapentin is no longer recommended because of problematic adverse effects, and continuous thoracic paravertebral block is no longer advised.
- The authors conclude that single-shot regional techniques are valuable and considered broadly equivalent to one another, though the abstract reports no pooled effect sizes.
AI summary not available. Read the source abstract on PubMed.
- Systematic review and meta-analysis of eight retrospective cohort studies, covering 311,402 ACDF patients including 8,182 GLP-1RA users matched to non-users.
- Compared perioperative GLP-1RA use with non-use for pseudarthrosis, reoperation, dysphagia, deep vein thrombosis, and readmission after ACDF.
- Lower pseudarthrosis odds at 6 months (OR 0.60, 95% CI 0.52 to 0.71), 12 months (OR 0.62, 0.53 to 0.73), and 24 months (OR 0.67, 0.57 to 0.79).
- Findings for reoperation, dysphagia, deep vein thrombosis, and readmission were heterogeneous and inconsistent, so evidence on other complications is inconclusive.
- Systematic review and meta-analysis of 75 studies (2,023 critically ill patients, 642 controls) from 1988 to 2024, mostly using vastus lateralis biopsies.
- Random-effects pooling compared myofiber cross-sectional area and protein turnover in critically ill adults against non-ICU controls.
- Myofiber area was 22% lower before ICU discharge (MD -689 µm²; 95% CI -1265 to -113; p = 0.02) and after discharge (MD -775 µm²; 95% CI -1512 to -37; p = 0.04).
- Protein synthesis did not differ significantly from controls (MD 0.007%/hr; 95% CI -0.010 to 0.027; p = 0.36), while degradation markers were consistently higher.
- Systematic review and meta-analysis of 8 randomized trials with 916 children receiving sevoflurane-based general anesthesia, comparing esketamine with placebo.
- Esketamine was compared with placebo for preventing emergence delirium, with no significant differences across dosing, surgery type, route, or timing.
- Emergence delirium was reduced with esketamine (RR 0.35; 95% CI 0.26-0.48; p<0.0001), and postoperative pain scores were lower (SMD -0.58).
- Extubation was modestly prolonged by 1.72 minutes, and nausea and vomiting were reduced (RR 0.69); certainty was moderate for most outcomes, low for extubation time.
- Systematic review and meta-analysis of 15 studies (16 cohorts, about 2.6 million encounters) of children under 18 with suspected infection in hospital settings.
- Evaluated the Phoenix Sepsis Criteria for in-hospital mortality and compared them with the IPSCC criteria.
- Pooled PSC sensitivity was 0.77 (95% CI, 0.67-0.85), specificity 0.73 (95% CI, 0.51-0.87), and AUC 0.81 (95% CI, 0.75-0.84), versus an IPSCC AUC of 0.71.
- The authors conclude the PSC has good prognostic accuracy but varies by setting, with ICU specificity 0.48 versus 0.99 in the ED, and it is intended for risk stratification rather than frontline screening.
- Systematic review and meta-analysis of 30 supervised and 12 unsupervised aerobic exercise studies, including 3157 and 1848 adult clinical patients.
- Compared supervised and unsupervised moderate-to-high-intensity aerobic exercise, each against controls; no included study directly compared the two supervision modes.
- Supervised exercise was associated with higher peak oxygen consumption (cumulative mean difference 0.88 ml/min/kg, 95% CI 0.49-1.27) and fewer complications (OR 0.60, 95% CI 0.39-0.93, P=0.026).
- Both supervised and unsupervised exercise improved 6MWT distance, and the authors note that the lack of direct comparisons limits the findings.